Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd2005.pdf
Reference133 articles.
1. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final Report. Circulation 106, 3143–3421 (2002). The 2001 NCEP report sparked increased interest of the medical community in the metabolic syn-drome. It led to new research as well as controversy about the clinical utility of the syndrome.
2. Grundy, S. M. et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433–438 (2004).
3. Grundy, S. M. et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109, 551–556 (2004).
4. Eckel, R. H., Grundy, S. M. & Zimmet, P. Z. The metabolic syndrome: epidemiology, mechanisms, and therapy. Lancet 365, 1415–1428 (2005). Reviews the worldwide epidemiology, pathophysiology and management of the metabolic syndrome.
5. Isomaa, B. et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689 (2001).
Cited by 225 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Supercharging metabolic health with Lycium barbarum L.: A review of the therapeutic potential of this functional food for managing metabolic syndrome;Food Frontiers;2024-01-10
2. Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches;Food Chemistry Advances;2023-12
3. A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records;eBioMedicine;2023-08
4. Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling;Marine Drugs;2023-05-17
5. Assessment of Cost and Diabetes Management Due to Polypharmacy in Iran Based on Haemoglobin A1c Levels, A Cross Sectional National Study;2023-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3